97-15633. Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 62, Number 115 (Monday, June 16, 1997)]
    [Notices]
    [Pages 32618-32619]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-15633]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Advisory Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Circulatory System Devices Panel of the Medical 
    Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA regulatory issues.
        Date and Time: The meeting will be held on July 28, 1997, 9:30 a.m. 
    to 6 p.m., and July 29, 1997, 8:30 a.m. to 3:30 p.m.
        Location: Holiday Inn--Gaithersburg, Walker/Whetstone Salons, Two 
    Montgomery Village Ave., Gaithersburg, MD.
        Contact Person: John E. Stuhlmuller, Center for Devices and 
    Radiological Health (HFZ-450), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-443-8243, ext. 157, or FDA 
    Advisory Committee
    
    [[Page 32619]]
    
    Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
    area), code 12625. Please call the Information Line for up-to-date 
    information on this meeting.
        Agenda: On July 28, 1997, the committee will discuss a premarket 
    approval application (PMA) for a transmyocardial revascularization 
    device. On July 29, 1997, the committee will discuss a PMA for a laser 
    sheath for pacing lead extraction.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by July 18, 1997. 
    Oral presentations from the public will be scheduled between 
    approximately 9:30 a.m. to 10:30 a.m. on July 28, 1997, and between 
    approximately 8:30 a.m. to 9:30 a.m. on July 29, 1997. Time allotted 
    for each presentation may be limited. Those desiring to make formal 
    oral presentations should notify the contact person before July 18, 
    1997, and submit a brief statement of the general nature of the 
    evidence or arguments they wish to present, the names and addresses of 
    proposed participants, and an indication of the approximate time 
    requested to make their presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
    
        Dated: June 9, 1997.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 97-15633 Filed 6-13-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
06/16/1997
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
97-15633
Pages:
32618-32619 (2 pages)
PDF File:
97-15633.pdf